These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15690240)

  • 41. Follow-up study of biological parameters in elderly institutionalized patients more than one year after discontinuation of calcium-vitamin D supplementation.
    Sebert JL; Fardellone P; Maamer M; Agbomson F; Brazier M; Garabedian M
    Rev Rhum Engl Ed; 1996; 63(7-8):498-501. PubMed ID: 8896064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unusual case of osteopenia associated with nutritional calcium and vitamin D deficiency in an adult dog.
    de Fornel-Thibaud P; Blanchard G; Escoffier-Chateau L; Segond S; Guetta F; Begon D; Delisle F; Rosenberg D
    J Am Anim Hosp Assoc; 2007; 43(1):52-60. PubMed ID: 17209086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatable lower motor neuron disease due to vitamin D deficiency and secondary hyperparathyroidism.
    Whitaker CH; Malchoff CD; Felice KJ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Sep; 1(4):283-6. PubMed ID: 11465022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D deficiency: appropriate replenishment therapies and the effects of vitamin D toxicity.
    Carlton S; Clopton D; Cappuzzo KA
    Consult Pharm; 2010 Mar; 25(3):171-7. PubMed ID: 20363711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paricalcitol in secondary hyperparathyroidism and the survival benefit in patients with chronic kidney disease.
    Al-Baaj F; Yadav P; Al-Rifai A
    J Ren Care; 2011 Jun; 37(2):75-9. PubMed ID: 21561542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac calcification in uremia.
    Rostand SG; Sanders PC; Rutsky EA
    Contrib Nephrol; 1994; 106():26-9. PubMed ID: 8174373
    [No Abstract]   [Full Text] [Related]  

  • 47. Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients.
    Chapuy MC; Chapuy P; Thomas JL; Hazard MC; Meunier PJ
    Rev Rhum Engl Ed; 1996 Feb; 63(2):135-40. PubMed ID: 8689285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secondary hyperparathyroidism in nutritional osteomalacia.
    Rizvi SN; Vaishinava H
    J Indian Med Assoc; 1975 Apr; 64(8):199-204. PubMed ID: 1080494
    [No Abstract]   [Full Text] [Related]  

  • 49. [Calcification of heart valves in hemodialized patients and their cardiosurgical correction].
    Dabrowski J; Stazka J; Janicka L; Madro E
    Kardiol Pol; 2004 Aug; 61(8):151-5; discussion 155. PubMed ID: 15457282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypothesis: the case for quaternary hyperparathyroidism.
    Brain HP; Sharma AK; Nussey SS
    Med Hypotheses; 2004; 62(5):701-3. PubMed ID: 15082092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin D deficiency and myocardial diseases.
    Pilz S; Tomaschitz A; Drechsler C; Dekker JM; März W
    Mol Nutr Food Res; 2010 Aug; 54(8):1103-13. PubMed ID: 20352623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serious cardiac and pulmonary calcification in a young peritoneal dialysis patient: potential role of continuous correction of acidosis.
    Nakagawa M; Kise K; Okamoto N; Fujino H; Iwai M; Nomura Y; Sawa H
    Clin Nephrol; 2005 Apr; 63(4):313-6. PubMed ID: 15847261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Third metatarsal brown tumor with secondary hyperparathyroidism: an atypical localization.
    Yazgan P; Ozturk A; Orhan I; Sirmatel O; Baba F
    J Am Podiatr Med Assoc; 2008; 98(4):314-7. PubMed ID: 18685053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral vitamin D effects on PTH levels.
    Jenkins PG; Mazumdar DC
    Am J Kidney Dis; 2012 May; 59(5):738; author reply 738-9. PubMed ID: 22507651
    [No Abstract]   [Full Text] [Related]  

  • 56. Fatal cardiac calcifications secondary to primary hyperparathyroidism.
    Katz JH; Dias SM; Ferguson RP
    Am J Med; 1988 Jul; 85(1):122-3. PubMed ID: 3389374
    [No Abstract]   [Full Text] [Related]  

  • 57. Sclerochoroidal calcification associated with hypovitaminosis D.
    Ali ZC; David VP
    Can J Ophthalmol; 2017 Aug; 52(4):e121-e122. PubMed ID: 28774530
    [No Abstract]   [Full Text] [Related]  

  • 58. Vitamin D therapy and cardiac function in chronic kidney disease.
    Rajagopalan S; Chan CT
    JAMA; 2012 Jun; 307(21):2253; author reply 2254. PubMed ID: 22706820
    [No Abstract]   [Full Text] [Related]  

  • 59. Vitamin D therapy and cardiac function in chronic kidney disease.
    Slatopolsky E
    JAMA; 2012 Jun; 307(21):2254; author reply 2254-5. PubMed ID: 22706822
    [No Abstract]   [Full Text] [Related]  

  • 60. Vitamin D therapy and cardiac function in chronic kidney disease.
    Fourtounas C
    JAMA; 2012 Jun; 307(21):2253; author reply 2254. PubMed ID: 22706819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.